Syndromic Diagnosis: Attributes of Quality in Health Care

Achieving Quality Attributes in Health Care in our institutions has become a priority for contracting services and being able to offer high technological standards, including medical care, prioritization of examinations and procedures to patients that lead to a high degree of satisfaction both internally and externally of the institution.

The application of these quality attributes in healthcare depends to a great extent on the levels of adherence and adoption of these attributes within the institutions and they have an evaluation system that allows the identification of critical points and opportunities for improvement in order to achieve internal and external satisfaction. For this reason, it is important to understand the difference between the attributes and to find tools that allow the complete implementation of them.

When we talk about accessibility We refer to the possibility that the user has to use the health services guaranteed by the General Social Security System, therefore it is the duty of all institutions to ensure access to the necessary technologies for users in terms of diagnosis and treatment definition.

At opportunity we are talking about the possibility that the user has to obtain the services he requires, without delays that put his life or health at risk, being this the main reason to demonstrate the importance of having a shorter diagnostic time to provide quality results in less time.

Security y continuityare two attributes that are much more focused on the quality of the results that are provided, with the reliability of the technologies that are in place in the institutions to maintain a logical sequence (rationality), practical and quick to allow decision making from the medical area to provide patients with treatment alternatives that are focused on the resolution of the pathology and the reduction of side effects associated with late diagnosis.

Finally, the relevancewhich refers to “the degree to which users obtain the services they require, with the best use of resources according to scientific evidence, and their side effects are less than the potential benefits”. Where we touched on the subject of efficiencies and reduction of waste in health care. in healthcare.

This is why, when the medical area is faced with a critical patient presenting an infectious syndrome, it is important to keep in mind that the main enemy is time, since every hour of waiting makes the difference in the decision of treatment and clinical outcome of patients. For example, when we talk about intra-abdominal infections, tissue infections, meningitis, respiratory infections, gastrointestinal infections or a septic process associated with these infections, every hour increases the percentage of mortality by 6-8%, so having the indicated diagnostic method that allows to decrease the time of delivery of the results will allow to adjust more quickly the protocols of empirical therapy towards targeted therapy, in addition to the application of infection control measures in real time, thus preventing progression and increasing the chances of patient survival and recovery.

It is here when the implementation of molecular technologies for syndromic diagnosis plays a very important role in reducing adverse events in patients during their hospital stay, in addition to reducing the possibility of the patient acquiring other intrahospital infections, resistant strains and exposure to broad-spectrum antibiotics that generate ototoxic, nephrotoxic, hepatotoxic effects, among others. In addition, these molecular technologies contribute greatly to the potentialization and establishment of the PROA (antibiotic optimization program), which seeks the adequate use and rationalization of antibiotics in the institutions.

Syndromic diagnostic panels are therefore a very useful tool, allowing reliable results in a short time, for critical patients such as immunocompromised, oncologic, transplanted, HIV, neonatal, pediatric, elderly, chronic patients, patients with comorbidities or with certain risk factors that increase the likelihood that these infectious syndromes can progress or worsen more rapidly causing serious complications such as sepsis and may even leave sequelae in patients.

By identifying not only a wide range of microorganisms, but also having the possibility of detecting resistance mechanisms in a single molecular test, it is very important that in the institutions where it is implemented, GPCs (Clinical Practice Guidelines) are originated, adapted or adopted, which clearly describe the diagnostic algorithms and profiling of patients in which the panels will be applied, in order to achieve effective recovery of these and avoid glosses that lead to difficulties in the ordering of these tests. This ensures that these tests are used in a pertinent manner according to the patient’s profile and that the medical area makes use of this valuable tool in a rational manner, with the purpose of achieving efficiency in health services and keeping in mind the quality attributes that are part of our General System of Social Security in Health.

Thinking about the needs of our health system and those of our own institutions, from Annar Health Technologies, we offer technologies with high performance and quality standards, to support the implementation of quality attributes to our health processes, always with an accompaniment from the medical, scientific, commercial, consulting and risk management areas.